NCT03125551

Brief Summary

Dietary Supplements can affect platelet activation and aggregation, which could result in bleeding tendencies. This study wishes to evaluate the influence that these supplements has on platelet function using Rotational thromboelastometry.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2017

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 24, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

May 9, 2018

Status Verified

May 1, 2018

Enrollment Period

1 month

First QC Date

March 27, 2017

Last Update Submit

May 3, 2018

Conditions

Keywords

Dietary supplementsBleeding tendency

Outcome Measures

Primary Outcomes (1)

  • Platelet dysfunction determined by ROTEM when consuming ginger, garlic, ginkgo biloba and ginseng.

    To determine if viscoelastic point-of-care coagulation monitoring (ROTEM) detects abnormalities in platelet function when subjects consume ginger, garlic, ginkgo biloba and ginseng within their recommended daily allowances. ExTEM and FibTEM analysis will be performed and difference in MCF values will determine if there is platelet dysfunction or not.

    2-4 weeks

Study Arms (5)

Ginger

ACTIVE COMPARATOR

Ginger ( Zingiber officinale) 4 grams po dly for 14 days

Dietary Supplement: Ginger

Garlic

ACTIVE COMPARATOR

Garlic (Allium sativum) 4-12 mg alliin po dly for 14 days

Dietary Supplement: Garlic

Ginkgo Biloba

ACTIVE COMPARATOR

Ginkgo Biloba 40mg po tds for 14 days

Dietary Supplement: Ginkgo Biloba

Ginseng

ACTIVE COMPARATOR

Ginseng 400mg po dly for 14 days

Dietary Supplement: Ginseng

Placebo

PLACEBO COMPARATOR

Placebo po dly for 14 days

Other: Placebo

Interventions

GingerDIETARY_SUPPLEMENT

Ginger dosage at daily recommended allowance

Ginger
GarlicDIETARY_SUPPLEMENT

Garlic dosage at daily recommended allowance

Garlic
Ginkgo BilobaDIETARY_SUPPLEMENT

Ginkgo Biloba dosage at daily recommended allowance

Ginkgo Biloba
GinsengDIETARY_SUPPLEMENT

Ginseng dosage at daily recommended allowance

Ginseng
PlaceboOTHER

Daily dosage strategy

Placebo

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-60 years
  • Both males and females
  • Healthy volunteers
  • Smokers and Non-smokers
  • Staff frequenting the theatre complex at Steve Biko Academic Hospital

You may not qualify if:

  • History of any chronic medical or psychiatric illness.
  • Current excessive alcohol intake - more than 14 units a week in woman and more than 21 units a week in men.
  • Pregnant or lactating mothers.
  • Possible planned surgery during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hemostatic Disorders

Interventions

ginger extractGinkgo ExtractAsian ginseng

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Plant ExtractsPlant PreparationsBiological ProductsComplex Mixtures

Study Officials

  • Jayde V Wyngaard, MBCHB

    University of Pretoria

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Each participant will be blinded to the dietary supplement which they will be taking. The medical technologist doing the ROTEM will be blinded to the dietary supplements as well.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Five- armed, placebo- controlled ( 4 intervention groups and 1 placebo group)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 27, 2017

First Posted

April 24, 2017

Study Start

June 1, 2017

Primary Completion

July 1, 2017

Study Completion

August 1, 2017

Last Updated

May 9, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share